101 related articles for article (PubMed ID: 2421879)
1. Complement-mediated lysis of K562 human leukemic cells by antibodies to phosphotyrosine and identification of cell surface proteins phosphorylated on tyrosine.
Ogawa R; Ohtsuka M; Watanabe Y
Cancer Res; 1986 May; 46(5):2507-10. PubMed ID: 2421879
[TBL] [Abstract][Full Text] [Related]
2. Immunofluorescent staining of human leukemic cells with monoclonal antibody to phosphotyrosine.
Ogawa R; Ohtsuka M; Watanabe Y; Noguchi K; Arimori S; Sasadaira H
Jpn J Cancer Res; 1985 Jul; 76(7):567-9. PubMed ID: 2411704
[TBL] [Abstract][Full Text] [Related]
3. Increase of phosphotyrosine-containing proteins in human carcinomas.
Ogawa R; Ohtsuka M; Sasadaira H; Hirasa M; Yabe H; Uchida H; Watanabe Y
Jpn J Cancer Res; 1985 Nov; 76(11):1049-55. PubMed ID: 2418000
[TBL] [Abstract][Full Text] [Related]
4. CD15 monoclonal antibodies react with a phosphotyrosine-containing protein on the surface of human neutrophils.
Skubitz KM; Mendiola JR; Collett MS
J Immunol; 1988 Dec; 141(12):4318-23. PubMed ID: 2461989
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal antibodies to an artificial immunogen, specifically demonstrating phosphotyrosine-containing proteins].
Paniutich AV; Rubikaĭte BI; Voĭtenok NN; Shidlovskaia EA; Grokhovskiĭ SL; Zhuze AL; Favorova OO
Bioorg Khim; 1989 Aug; 15(8):1060-9. PubMed ID: 2480131
[TBL] [Abstract][Full Text] [Related]
6. CD31 (PECAM-1), CDw32 (Fc gamma RII), and anti-HLA class I monoclonal antibodies recognize phosphotyrosine-containing proteins on the surface of human neutrophils.
Skubitz KM; Goueli SA
J Immunol; 1994 Jun; 152(12):5902-11. PubMed ID: 7515918
[TBL] [Abstract][Full Text] [Related]
7. The effects of specific antibody-complement-mediated cytotoxicity on transformed and untransformed Syrian hamster cells.
Clarke SM; Fink LM
Cancer Res; 1977 Sep; 37(9):2985-92. PubMed ID: 328140
[TBL] [Abstract][Full Text] [Related]
8. Immunofluorescent quantification of tyrosine phosphorylation of cellular proteins in whole cells by flow cytometry.
Far DF; Peyron JF; Imbert V; Rossi B
Cytometry; 1994 Apr; 15(4):327-34. PubMed ID: 7517816
[TBL] [Abstract][Full Text] [Related]
9. Direct identification of phosphotyrosine-containing proteins in some retrovirus-transformed cells by use of anti-phosphotyrosine antibody.
Seki J; Owada MK; Sakato N; Fujio H
Cancer Res; 1986 Feb; 46(2):907-16. PubMed ID: 2416436
[TBL] [Abstract][Full Text] [Related]
10. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
[TBL] [Abstract][Full Text] [Related]
11. Highly specific characterization of tyrosine phosphoproteins in tumor cells based on monoclonal antibodies defined by conjugated phosphotyramine.
Steinhilber G; Sproll MW; Wolff JM; Anderer FA
Anticancer Res; 1990; 10(4):907-11. PubMed ID: 1696448
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiation.
Sugimoto T; Sawada T; Negoro S; Kidowaki T; Morioka H; Matsumura T; Kemshead JT; Seeger RC
Cancer Res; 1985 Jan; 45(1):358-64. PubMed ID: 2981159
[TBL] [Abstract][Full Text] [Related]
13. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of monoclonal antibodies to phosphotyrosine and their use for identification of phosphotyrosine-containing proteins].
Kharitonenkov AI; Kudriavtseva NG; Bulargina TV
Biokhimiia; 1989 Oct; 54(10):1732-9. PubMed ID: 2481508
[TBL] [Abstract][Full Text] [Related]
15. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
Zarcone D; Tilden AB; Friedman HM; Grossi CE
Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
[TBL] [Abstract][Full Text] [Related]
16. Detection of tyrosine phosphorylated proteins by combination of immunoaffinity enrichment, two-dimensional difference gel electrophoresis and fluorescent Western blotting.
Bergström Lind S; Hagner-McWhirter S; Elfineh L; Molin M; Jorsback A; Ohman J; Pettersson U
Biochem Biophys Res Commun; 2010 Oct; 401(4):581-5. PubMed ID: 20888324
[TBL] [Abstract][Full Text] [Related]
17. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
Helfand SC; Hank JA; Gan J; Sondel PM
Cell Immunol; 1996 Jan; 167(1):99-107. PubMed ID: 8548851
[TBL] [Abstract][Full Text] [Related]
18. Antibody-induced antigenic modulation is antigen dependent: characterization of 22 proteins on a malignant human B cell line.
Pesando JM; Hoffman P; Abed M
J Immunol; 1986 Dec; 137(11):3689-95. PubMed ID: 3491146
[TBL] [Abstract][Full Text] [Related]
19. Heparin inhibition of antibody-dependent complement-mediated lysis.
Wesolowski J; Ault K; Houghton R; Parkman R
Exp Hematol; 1984 Oct; 12(9):700-5. PubMed ID: 6237929
[TBL] [Abstract][Full Text] [Related]
20. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
